Estimates of the mean annual standardized IPF incidence rates (per 100,000 person-years) in Lombardy during the period 2005–2010 by gender, age, and case definition.

<p>Estimates of the mean annual standardized IPF incidence rates (per 100,000 person-years) in Lombardy during the period 2005–2010 by gender, age, and case definition.</p

Criteria applied in general, broad and narrow case definitions for IPF.

<p>Criteria applied in general, broad and narrow case definitions for IPF.</p

Trend in age-sex standardized annual incidence rates (per 100,000 person-years) of IPF in Lombardy during 2005–2010 by case definition.

<p>(A) General case definition. (B) Broad case definition. (C) Narrow case definition. Grey bands indicate 95% confidence intervals.</p

Results of Poisson regression models on expected prevalence rates in the reference population (population of Lombardy at January 1^st 2010).

<p>Results of Poisson regression models on expected prevalence rates in the reference population (population of Lombardy at January 1^st 2010).</p

Results of Poisson regression models on expected incidence rates in the reference population (population of Lombardy at January 1^st 2010).

<p>Results of Poisson regression models on expected incidence rates in the reference population (population of Lombardy at January 1^st 2010).</p

Trend in age-sex standardized annual prevalence rates (per 100,000 person-years) of IPF in Lombardy during 2005–2010, by case definition.

<p>(A) General case definition. (B) Broad case definition. (C) Narrow case definition. Grey bands indicate 95% confidence intervals.</p

Demographic characteristics of prevalent and incident cases of IPF from 2005 to 2010 in Lombardy by case definition.

<p>Demographic characteristics of prevalent and incident cases of IPF from 2005 to 2010 in Lombardy by case definition.</p

Estimates of the mean annual standardized IPF prevalence rates (per 100,000 person-years) in Lombardy during the period 2005–2010 by gender, age, and case definition.

<p>Estimates of the mean annual standardized IPF prevalence rates (per 100,000 person-years) in Lombardy during the period 2005–2010 by gender, age, and case definition.</p

Additional file 6: of Immunocompromised patients with acute respiratory distress syndrome: secondary analysis of the LUNG SAFE database

Table S6. Ventilator settings during the first day of ARDS in immunocompetent (Control) and immunocompromised (Study) patients, stratified by the type of ventilatory support (IMV, NIV, NIV failure). (PDF 60 kb

Additional file 5: of Immunocompromised patients with acute respiratory distress syndrome: secondary analysis of the LUNG SAFE database

Table S4. Adjunctive measures/therapies during at least one day during follow-up in immunocompetent and immunocompromised patients. This table shows the proportions of adjunctive measures/therapies during at least one day during follow-up in immunocompetent and immunocompromised patients. (PDF 97 kb